Financial Advocates Investment Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$479K Sell
6,944
-8,515
-55% -$588K 0.04% 365
2025
Q1
$1.07M Buy
15,459
+1,875
+14% +$130K 0.08% 264
2024
Q4
$1.17M Sell
13,584
-4,165
-23% -$358K 0.07% 268
2024
Q3
$2.11M Buy
17,749
+10
+0.1% +$1.19K 0.12% 176
2024
Q2
$2.53M Sell
17,739
-5,522
-24% -$788K 0.16% 145
2024
Q1
$2.99M Buy
23,261
+222
+1% +$28.5K 0.17% 131
2023
Q4
$2.38M Sell
23,039
-304
-1% -$31.4K 0.16% 149
2023
Q3
$2.12M Buy
23,343
+5,815
+33% +$529K 0.15% 152
2023
Q2
$1.42M Buy
17,528
+804
+5% +$65.1K 0.1% 209
2023
Q1
$1.33M Buy
16,724
+1,376
+9% +$109K 0.1% 228
2022
Q4
$1.04M Buy
15,348
+7,916
+107% +$536K 0.08% 273
2022
Q3
$560K Sell
7,432
-7,406
-50% -$558K 0.05% 379
2022
Q2
$826K Buy
14,838
+2,938
+25% +$164K 0.07% 300
2022
Q1
$660K Buy
11,900
+5,498
+86% +$305K 0.04% 389
2021
Q4
$358K Sell
6,402
-110
-2% -$6.15K 0.02% 578
2021
Q3
$312K Buy
+6,512
New +$312K 0.02% 607
2020
Q3
Sell
-6,560
Closed -$215K 656
2020
Q2
$215K Buy
+6,560
New +$215K 0.02% 529
2019
Q3
Sell
-11,444
Closed -$292K 495
2019
Q2
$292K Sell
11,444
-394
-3% -$10.1K 0.03% 371
2019
Q1
$310K Sell
11,838
-300
-2% -$7.86K 0.04% 355
2018
Q4
$280K Sell
12,138
-468
-4% -$10.8K 0.04% 350
2018
Q3
$297K Buy
12,606
+156
+1% +$3.68K 0.03% 392
2018
Q2
$291K Buy
12,450
+294
+2% +$6.87K 0.04% 375
2018
Q1
$300K Buy
12,156
+12
+0.1% +$296 0.04% 365
2017
Q4
$326K Buy
+12,144
New +$326K 0.04% 338